A new study suggests that gabapentin could provide greater benefit than FDA-approved drugs for patients with ...
Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and ...
The addictive behavior underlying many cases of ALD often goes unaddressed. Experts offer their advice on how ...
Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with ...
Maryland's prescription drug affordability board advanced cost reviews for six drugs, including Novo Nordisk’s Ozempic, Eli ...
For example, acamprosate and/or coadministered naltrexone for 3 months reduced relapse rates from 75% (placebo) to 50–60% (either drug alone) and 25% (combination treatment). [8] Disulfiram ...
6don MSN
Alcohol is responsible for more deaths than overdoses from opioids and all other substances combined, yet less than 10% of ...
From the Division of Preventive Medicine (C.M.A., J.E.M., N.R.C, U.A.A., J.M.G., C.H.H) and Cardiovascular Medicine (J.M.G.), Department of Medicine, Brigham and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback